While peripheral hyperinsulinaemia contribute to the development of Alzheimer’s disease, the administration of intranasal insulin, which travels directly into the central nervous system, may enhance cognition in patients with early Alzheimer’s disease or Mild Cognitive Impairment [10]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.